MatsukiyoCocokara & Co.

3088

JP3869010003

Drug Retailers

Delayed Japan Exchange Other stock markets 12:43:33 2024-04-25 am EDT			5-day change	1st Jan Change
2,244 ^JPY	+0.34%		-1.60%	-10.17%

Feb. 28	Aeon Co. Plans to Merge Japan Drugstore Unit Welcia With Rival Tsuruha -- 2nd Update	DJ
Feb. 28	Aeon Co. Plans to Merge Japan Drugstore Unit Welcia With Rival Tsuruha -- Update	DJ

Matsumotokiyoshi Holdings Co., Ltd. authorizes a Buyback Plan.

May 12, 2021

The Board of Directors of Matsumotokiyoshi Holdings Co., Ltd. has authorized a buyback plan on May 13, 2021.

Latest news about MatsukiyoCocokara & Co.

Aeon Co. Plans to Merge Japan Drugstore Unit Welcia With Rival Tsuruha -- 2nd Update	Feb. 28	DJ
Aeon Co. Plans to Merge Japan Drugstore Unit Welcia With Rival Tsuruha -- Update	Feb. 28	DJ
Aeon Co. Weighs Merger of Drugstore Unit Welcia With Rival Tsuruha -- 3rd Update	Feb. 26	DJ
Tranche Update on MatsukiyoCocokara & Co.'s Equity Buyback Plan announced on November 14, 2023.	Nov. 14	CI
MatsukiyoCocokara & Co.'s Equity Buyback announced on November 14, 2023, has closed with 715,200 shares, representing 0.17% for ¥1,941.77 million.	Nov. 14	CI
MatsukiyoCocokara & Co. announces an Equity Buyback for 800,000 shares, representing 0.19% for ¥2,172 million.	Nov. 14	CI
MatsukiyoCocokara & Co. authorizes a Buyback Plan.	Nov. 13	CI
Tranche Update on MatsukiyoCocokara & Co.'s Equity Buyback Plan announced on August 10, 2023.	23-08-13	CI
MatsukiyoCocokara & Co.'s Equity Buyback announced on August 10, 2023, has closed with 200,000 shares, representing 0.14% for ¥1,742 million.	23-08-13	CI
MatsukiyoCocokara & Co. announces an Equity Buyback for 220,000 shares, representing 0.16% for ¥1,936 million.	23-08-10	CI
MatsukiyoCocokara & Co. authorizes a Buyback Plan.	23-08-09	CI
MatsukiyoCocokara & Co. Reports Earnings Results for the Full Year Ended March 31, 2023	23-05-12	CI
Morgan Stanley Adjusts MatsukiyoCocokara's Price Target to 8,300 Yen From 6,600 Yen, Keeps at Overweight	23-05-11	MT
Tranche Update on MatsukiyoCocokara & Co.'s Equity Buyback Plan announced on February 14, 2023.	23-02-14	CI
MatsukiyoCocokara & Co.'s Equity Buyback announced on February 14, 2023, has closed with 1,150,000 shares, representing 0.82% for ¥7,555.50 million.	23-02-14	CI
MatsukiyoCocokara & Co. announces an Equity Buyback for 1,250,000 shares, representing 0.89% for ¥8,500 million.	23-02-14	CI
MatsukiyoCocokara & Co. authorizes a Buyback Plan.	23-02-13	CI
Tranche Update on MatsukiyoCocokara & Co.'s Equity Buyback Plan announced on November 14, 2022.	22-11-14	CI
MatsukiyoCocokara & Co.'s Equity Buyback announced on November 14, 2022, has closed with 204,000 shares, representing 0.14% for ¥1,071 million.	22-11-14	CI
MatsukiyoCocokara & Co. announces an Equity Buyback for 230,000 shares, representing 0.16% for ¥1,500 million.	22-11-14	CI
MatsukiyoCocokara & Co. authorizes a Buyback Plan.	22-11-13	CI
MatsukiyoCocokara & Co.(TSE:3088) added to S&P Japan Mid Cap 100	22-09-20	CI
Nikkei hits over 7-month high on Wall Street optimism, robust earnings	22-08-15	RE
Japanese shares rise on Wall Street optimism, strong earnings	22-08-14	RE
Tranche Update on MatsukiyoCocokara & Co.'s Equity Buyback Plan announced on August 12, 2022.	22-08-14	CI

MatsukiyoCocokara & Co, formerly Matsumotokiyoshi Holdings Co Ltd, is engaged in retail business, wholesale business and management support business. Retail business is engaged in operating chain stores of drugstores and insurance pharmacies, opening and operating insurance dispensing pharmacies, dispatching pharmacists and others. Wholesale business purchases and sells products handled by group companies and business partners that engage in retail business, develops franchise businesses, and supplies products to franchisees. The Management Support segment is involved in the management of group companies and contracting of indirect business, planning and development of private brand products, asset management and operation, the construction and maintenance of stores, as well as the operation of non-life and life insurance agency business.

Sector

Drug Retailers

Calendar

2024-05-09 - Q4 2023 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for MatsukiyoCocokara & Co.

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

2,236 JPY

Average target price

3,103 JPY

Spread / Average Target

+38.76%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Drug Retailers

	1st Jan change	Capi.
MATSUKIYOCOCOKARA & CO.	-10.17%	6.01B
WALGREENS BOOTS ALLIANCE, INC.	-31.79%	15.36B
JD HEALTH INTERNATIONAL INC.	-35.93%	10.16B
YIFENG PHARMACY CHAIN CO., LTD.	+9.74%	6.13B
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED	-34.43%	5.65B
NAHDI MEDICAL COMPANY	-0.73%	4.71B
CORPORATIVO FRAGUA, S.A.B. DE C.V.	+52.93%	4.33B
CLICKS GROUP LIMITED	-11.96%	3.58B
WELCIA HOLDINGS CO., LTD.	-5.98%	3.1B
DASHENLIN PHARMACEUTICAL GROUP CO., LTD.	-18.03%	3.21B

Other Drug Retailers

MatsukiyoCocokara & Co.

Equities

3088

JP3869010003

Drug Retailers

Matsumotokiyoshi Holdings Co., Ltd. authorizes a Buyback Plan.

Latest news about MatsukiyoCocokara & Co.

Chart MatsukiyoCocokara & Co.

Company Profile

Income Statement Evolution

Ratings for MatsukiyoCocokara & Co.

Analysts' Consensus

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Other Drug Retailers